Literature DB >> 1319394

Chromosomal localization of FLT4, a novel receptor-type tyrosine kinase gene.

F Galland1, A Karamysheva, M G Mattei, O Rosnet, S Marchetto, D Birnbaum.   

Abstract

A new human gene encoding a putative receptor-type tyrosine kinase (RTK) was isolated by screening a placenta cDNA library with a mouse Flt3 probe. The deduced amino acid sequence of the intracellular region of the molecule showed that it was strongly related to the FLT1 and KDR/FLK1 gene products and to a lesser degree to members of the class III RTKs: FMS/CSF1R, PDGFRA/B, KIT, and FLT3. The gene was named FLT4. Cosmid clones of the mouse Flt4 gene were isolated. The human gene was localized to bands q34-q35 of chromosome 5, i.e., slightly telomeric to the CSF1R/PDGRFB tandem of genes, and the mouse homolog to chromosome 11, region A5-B1.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1319394     DOI: 10.1016/0888-7543(92)90277-y

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  12 in total

1.  Genomic organization of the extracellular coding region of the human FGFR4 and FLT4 genes: evolution of the genes encoding receptor tyrosine kinases with immunoglobulin-like domains.

Authors:  F Agnès; M M Toux; C André; F Galibert
Journal:  J Mol Evol       Date:  1997-07       Impact factor: 2.395

2.  Molecular evolution of the genes encoding receptor tyrosine kinase with immunoglobulinlike domains.

Authors:  D Rousset; F Agnès; P Lachaume; C André; F Galibert
Journal:  J Mol Evol       Date:  1995-10       Impact factor: 2.395

3.  Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4.

Authors:  J Lee; A Gray; J Yuan; S M Luoh; H Avraham; W I Wood
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

4.  VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema.

Authors:  Young-Sup Yoon; Toshinori Murayama; Edwin Gravereaux; Tengiz Tkebuchava; Marcy Silver; Cynthia Curry; Andrea Wecker; Rudolf Kirchmair; Chun Song Hu; Marianne Kearney; Alan Ashare; David G Jackson; Hajime Kubo; Jeffrey M Isner; Douglas W Losordo
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

5.  MYC high level gene amplification is a distinctive feature of angiosarcomas after irradiation or chronic lymphedema.

Authors:  Johanna Manner; Bernhard Radlwimmer; Peter Hohenberger; Katharina Mössinger; Stefan Küffer; Christian Sauer; Djeda Belharazem; Andreas Zettl; Jean-Michel Coindre; Christian Hallermann; Jörg Thomas Hartmann; Detlef Katenkamp; Kathrin Katenkamp; Patrick Schöffski; Raf Sciot; Agnieszka Wozniak; Peter Lichter; Alexander Marx; Philipp Ströbel
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

Review 6.  Molecular mechanisms of lymphangiogenesis.

Authors:  Meiko Takahashi; Takanobu Yoshimoto; Hajime Kubo
Journal:  Int J Hematol       Date:  2004-07       Impact factor: 2.490

7.  Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth.

Authors:  K G Peters; C De Vries; L T Williams
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

8.  Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium.

Authors:  T P Quinn; K G Peters; C De Vries; N Ferrara; L T Williams
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

9.  Cloning, expression, and distribution of a Ca(2+)-activated K+ channel beta-subunit from human brain.

Authors:  J Tseng-Crank; N Godinot; T E Johansen; P K Ahring; D Strøbaek; R Mertz; C D Foster; S P Olesen; P H Reinhart
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-20       Impact factor: 11.205

Review 10.  The role of vascular endothelial growth factor in wound healing.

Authors:  Philip Bao; Arber Kodra; Marjana Tomic-Canic; Michael S Golinko; H Paul Ehrlich; Harold Brem
Journal:  J Surg Res       Date:  2008-05-12       Impact factor: 2.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.